Trial Type: Acute Lymphoblastic Leukemia (Pediatric)

A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias

Post induction inotuzumab for newly diagnosed ALL

Imatinib with two different chemotherapy combinations for PH+ ALL

Inotuzumab for relapsed ALL